Matthew Korenberg E.'s most recent trade in Lifecore Biomedical Inc was a trade of 19,506 Common Stock done . Disclosure was reported to the exchange on July 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifecore Biomedical Inc | Matthew E. Korenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 19,506 | 44,060 (0%) | 0% | - | Common Stock | |
| Palvella Therapeutics Inc. | Matthew Korenberg E. | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 123,559 | 123,559 | - | - | Non-Qualified Stock Option (right to buy) | |
| Palvella Therapeutics Inc. | Matthew Korenberg E. | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 5,373 | 5,373 | - | - | Incentive Stock Option (right to buy) |